Yan Mao Meng Lv Yongmei Wang Weihong Cao Wenfeng Li
10.3389/fonc.2022.1022913
Front Oncol
2023 Jan 9;12:1022913.
cdk4/6 inhibitor abemaciclib breast cancer case report metastatic
CC BY
https://pubmed.ncbi.nlm.nih.gov/36698413/
Case Reports
PMC9869123
36698413
Hormone receptor-positive, HER2-negative, metastatic breast cancer responded well to abemaciclib and exemestane after palbociclib and fulvestrant failure: A case report and literature review
2023